T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Hanover Insurance
THG
$7.77B
| $131M | 0.02% |
965,238
-136
| -0% | -$17.6K |
|
502
Celldex Therapeutics
CLDX
$3.35B
| $130M | 0.02% |
3,087,208
+2,664,915
| +631% | +$109M |
|
503
Kosmos Energy
KOS
$1.51B
| $126M | 0.02% |
21,147,575
-1,746,777
| -8% | -$10.5M |
|
504
Emerson Electric
EMR
$91.6B
| $126M | 0.02% |
1,106,633
+149,446
| +16% | +$15.4M |
|
505
HDFC Bank
HDB
$119B
| $123M | 0.02% |
4,398,514
-218,378
| -5% | -$6.19M |
|
|
ALPN
506
DELISTED
Alpine Immune Sciences Inc
ALPN
| $122M | 0.02% |
3,080,220
+1,392,942
| +83% | +$41.1M |
|
507
Apple Hospitality REIT
APLE
$3.75B
| $121M | 0.01% |
7,398,673
+253,082
| +4% | +$4.14M |
|
508
Onto Innovation
ONTO
$20.6B
| $121M | 0.01% |
669,202
-277,677
| -29% | -$46.9M |
|
509
Johnson Controls International
JCI
$91.7B
| $121M | 0.01% |
1,853,753
-20,703
| -1% | -$1.21M |
|
510
Paychex
PAYX
$44.6B
| $120M | 0.01% |
979,513
+6,020
| +0.6% | +$731K |
|
511
Alexandria Real Estate Equities
ARE
$8.33B
| $119M | 0.01% |
926,939
-5,794
| -0.6% | -$714K |
|
512
XP
XP
$8.18B
| $119M | 0.01% |
4,635,683
-294,194
| -6% | -$7.38M |
|
513
Krystal Biotech
KRYS
$9.72B
| $117M | 0.01% |
658,618
+231,255
| +54% | +$32.1M |
|
514
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
| $117M | 0.01% |
1,048,800
+53,120
| +5% | +$5.31M |
|
515
Planet Fitness
PLNT
$3.71B
| $116M | 0.01% |
1,859,366
+483,586
| +35% | +$32.3M |
|
516
Duke Energy
DUK
$97.1B
| $116M | 0.01% |
1,203,916
+16,735
| +1% | +$1.59M |
|
517
TC Energy
TRP
$65.8B
| $115M | 0.01% |
2,868,223
-708,214
| -20% | -$27.9M |
|
518
Kilroy Realty
KRC
$4.3B
| $115M | 0.01% |
3,162,748
+487,556
| +18% | +$18M |
|
519
CBRE Group
CBRE
$44B
| $115M | 0.01% |
1,179,894
-193,731
| -14% | -$17.4M |
|
520
Kimco Realty
KIM
$16.4B
| $115M | 0.01% |
5,846,943
+1,381,490
| +31% | +$27.5M |
|
521
Fastenal
FAST
$58.9B
| $115M | 0.01% |
2,972,560
-3,062
| -0.1% | -$108K |
|
522
Waste Management
WM
$89.6B
| $114M | 0.01% |
532,819
+18,429
| +4% | +$3.62M |
|
|
DFS
523
DELISTED
Discover Financial Services
DFS
| $113M | 0.01% |
863,319
-393,767
| -31% | -$45.1M |
|
|
SRCL
524
DELISTED
Stericycle Inc
SRCL
| $113M | 0.01% |
2,141,701
-1,231,649
| -37% | -$62M |
|
525
Agnico Eagle Mines
AEM
$91.3B
| $113M | 0.01% |
1,888,061
-183,338
| -9% | -$9.39M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.